| Market Capitalization (Millions $) |
3 |
| Shares
Outstanding (Millions) |
5 |
| Employees |
4 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-37 |
| Cash Flow (TTM) (Millions $) |
-4 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Conduit Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel therapies for the treatment of various cancers. The company uses a unique approach that involves targeting specific biological pathways involved in tumor growth and metastasis.
Conduit Pharmaceuticals aims to address unmet medical needs in oncology by developing innovative drugs that have the potential to improve patient outcomes. Their research and development efforts focus on discovering and advancing small molecule drugs that selectively modulate key signaling pathways associated with cancer progression.
The company's pipeline includes several drug candidates at various stages of development, targeting different types of cancers such as breast, lung, and ovarian. These candidates have shown promising results in preclinical and early-stage clinical trials, demonstrating their potential to become effective treatments.
Conduit Pharmaceuticals distinguishes itself by combining scientific expertise, advanced technologies, and strategic collaborations to accelerate the drug discovery and development process. The company is committed to advancing its pipeline and bringing novel therapies to patients in need.
Company Address: 4581 Tamiami Trail North Naples 34103 FL
Company Phone Number: 491-9132 Stock Exchange / Ticker: NASDAQ CDT
|
4.68%